Hinge Health, Inc. logo HNGE - Hinge Health, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $65.82 DETAILS
HIGH: $95.00
LOW: $45.00
MEDIAN: $63.00
CONSENSUS: $65.82
UPSIDE: 19.13%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2
Revenue
Revenue 182.3 170.7 154.2 139.1 123.8 117.3 100.6 89.8 82.7 81.5 81.4 69.8
Cost of Revenue 28.1 26.6 28.0 40.4 23.6 21.2 21.4 23.2 24.8 23.0 23.2 26.2
Gross Profit 154.2 144.2 126.2 98.7 100.2 96.1 79.2 66.6 57.9 58.5 58.1 43.6
Operating Expenses
R&D Expenses 30.3 32.8 31.9 282.3 23.5 22.4 23.8 24.9 30.8 28.6 28.5 27.8
SG&A Expenses 91.8 83.5 100.4 398.5 63.6 52.3 59.3 59.2 59.6 60.4 52.0 53.0
Other Expenses 0 0.7 0.0 (1.4) 0 0.6 (0.0) 0 (1) 0 0 0
Operating Expenses 122.2 116.9 132.3 679.3 87.1 75.2 83.1 84.2 89.4 89.0 80.4 80.8
Operating Income
Operating Income 32.1 27.3 (6.1) (580.7) 13.1 20.9 (3.8) (17.6) (31.4) (30.5) (22.3) (37.1)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA 32.1 29.7 (5.5) (580.1) 13.6 22.7 (3.2) (17.0) (30.8) (24.5) (16.6) (31.7)
EBIT 32.1 28.5 (6.1) (580.7) 13.1 21.3 (3.9) (17.6) (31.4) (24.6) (16.7) (31.8)
Income Before Tax 35.9 32.2 (1.6) (680.2) 122.3 26.2 1.4 (12.6) (26.3) (24.6) (16.7) (31.8)
Income Tax Expense 0.8 0.1 0.2 0.3 1.0 1.0 1.1 0.4 0.2 (0.4) 0.0 0
Net Income 35.1 32.1 (1.8) (679.8) 121.3 27.1 0.3 (12.9) (26.5) (24.1) (16.8) (31.8)
Per Share Data
EPS (Basic) 0.43 0.39 -0.02 -7.38 1.55 0.35 0.00 -0.19 -0.34 -0.31 -0.21 -0.41
EPS (Diluted) 0.41 0.37 -0.02 -7.38 1.55 0.35 0.00 -0.14 -0.34 -0.31 -0.21 -0.41
Shares Outstanding 78.6 79.5 78.9 78.0 78.0 78.0 78.0 68.5 78.0 78.0 78.0 78.0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q1
Current Assets
Cash & Cash Equivalents 188.1 208.0 261.3 237.2 288.5 302.6 0
Short-Term Investments 129.2 155.9 218.7 176.1 182.3 165.8 0
Net Receivables 114.9 66.1 86.8 99.3 75.9 42.5 0
Inventory 14.2 15.6 13.8 14.0 12.8 24.9 0
Other Current Assets 59.2 57.4 53.3 45.5 44.0 5.1 (423.4)
Total Current Assets 505.5 533.9 658.9 598.4 618.3 564.8 0
Non-Current Assets
Property, Plant & Equipment 17.3 17.4 16.1 16.3 15.8 17.0 0
Goodwill 64.1 64.1 64.1 64.1 64.1 61.6 0
Intangible Assets 2.3 2.5 2.7 3.0 3.2 1.8 0
Long-Term Investments 89.8 113.2 15.1 0 0 0 0
Other Non-Current Assets 49.8 13.7 12.9 11.8 11.2 27.0 0
Total Non-Current Assets 223.2 210.9 110.9 95.2 94.3 110.6 0
Total Assets 728.8 744.8 769.8 693.7 712.5 675.5 0
Current Liabilities
Account Payables 69.5 0 0 0 0 0 0
Short-Term Debt 4.2 0 0 0 0 3.8 0
Deferred Revenue 340.8 300.9 299.7 0 217.3 217.6 0
Other Current Liabilities 0 11.5 15.1 282.9 6.7 17.8 0
Total Current Liabilities 414.5 362.4 357.1 314.1 267.5 249.3 0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 7.3 0
Deferred Tax Liabilities 0 0 0 0 0 2.2 0
Other Non-Current Liabilities 0 0 0 0 0 (7.3) (427.3)
Total Non-Current Liabilities 2.7 3.8 4.9 5.9 6.2 9.5 (427.3)
Total Liabilities 417.2 366.2 361.9 320.0 273.7 258.8 (427.3)
Stockholders' Equity
Common Stock 0 0 0 0 0 0 0
Retained Earnings (1,015.9) (1,051.0) (1,083.1) (1,081.2) (505.6) (522.7) 0
Accumulated Other Comprehensive Income (0.3) (0.0) 0.1 (0.0) 0.0 0.1 (424.0)
Total Stockholders' Equity 311.6 378.5 407.9 373.7 438.8 416.7 427.3
Total Liabilities & Equity 728.8 744.8 769.8 693.7 712.5 675.5 0
Debt Metrics
Total Debt 7.0 8.0 9.0 10.0 10.1 18.3 0
Net Debt (181.1) (200.0) (252.3) (227.2) (278.4) (284.3) 0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1
Operating Activities
Net Income 35.1 32.1 (1.8) (575.7) 17.1 27.1 0.3 (12.9) (26.5)
Depreciation & Amortization 1.3 1.2 0 1.3 1.3 1.4 8.9 1.6 1.6
Stock-Based Compensation 11.7 17.2 0 591.0 0.0 0.0 0.1 0.3 0.3
Change in Working Capital (22.2) (1.3) 34.0 (10.2) (24.5) (1.2) (5.6) 15.0 (16.9)
Other Non-Cash Items 17.1 14.8 50.2 13.7 11.0 11.6 24.7 11.0 8.8
Operating Cash Flow 43.1 63.9 82.4 20.2 4.9 38.3 28.4 14.9 (32.7)
Investing Activities
Capital Expenditure (0.1) (0.4) (1.1) (1.8) (0.8) (1.0) (0.3) (0.9) (0.9)
Acquisitions 0 0 0 0 (4) 0 0 0 0
Purchases of Investments (59.0) (154.1) (142.9) (85.1) (90.2) (83.3) 0 (84.5) (76.3)
Sales/Maturities of Investments 108.6 118.8 85.3 91.0 73.6 81.2 0 88.1 93.5
Other Investing Activities (1.4) (2.0) 0 0 (0.7) (0.9) 2.8 (0.5) (0.8)
Investing Cash Flow 48.1 (37.7) (58.8) 4.0 (21.3) (3.1) 2.5 2.7 16.2
Financing Activities
Net Debt Issuance 0 0 0 0 4.9 0 0 0 0
Stock Repurchased (105.0) (65.0) 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities (8.3) (23.3) 0 (331.4) (0.8) (2.3) (0.0) 0.1 0.1
Financing Cash Flow (112.8) (79.5) 0.5 (75.6) 4.1 (2.3) (0.0) 0.1 0.1
Cash Position
Net Change in Cash (21.7) (53.3) 24.2 (51.3) (12.3) 32.9 30.9 17.7 (16.4)
Cash at Beginning 209.8 263.1 239.0 288.5 302.6 269.7 238.8 221.1 237.5
Cash at End 188.1 209.8 263.1 237.2 290.3 302.6 269.7 238.8 221.1
Free Cash Flow 43 63.5 81.3 18.4 4.2 37.3 28.1 14.0 (33.6)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2
Income Statement
Revenue 182.3 170.7 154.2 139.1 123.8 117.3 100.6 89.8 82.7 81.5 81.4 69.8
Gross Profit 154.2 144.2 126.2 98.7 100.2 96.1 79.2 66.6 57.9 58.5 58.1 43.6
Operating Income 32.1 27.3 (6.1) (580.7) 13.1 20.9 (3.8) (17.6) (31.4) (30.5) (22.3) (37.1)
Net Income 35.1 32.1 (1.8) (679.8) 121.3 27.1 0.3 (12.9) (26.5) (24.1) (16.8) (31.8)
EPS (Diluted) 0.41 0.37 -0.02 -7.38 1.55 0.35 0.00 -0.14 -0.34 -0.31 -0.21 -0.41
Balance Sheet
Cash & Equivalents 188.1 208.0 261.3 237.2 288.5 302.6 0
Total Assets 728.8 744.8 769.8 693.7 712.5 675.5 0
Total Debt 7.0 8.0 9.0 10.0 10.1 18.3 0
Stockholders' Equity 311.6 378.5 407.9 373.7 438.8 416.7 427.3
Cash Flow
Operating Cash Flow 43.1 63.9 82.4 20.2 4.9 38.3 28.4 14.9 (32.7)
Capital Expenditure (0.1) (0.4) (1.1) (1.8) (0.8) (1.0) (0.3) (0.9) (0.9)
Free Cash Flow 43 63.5 81.3 18.4 4.2 37.3 28.1 14.0 (33.6)